The board of directors of healthcare company Pfizer Inc (NYSE:PFE) declared an unchanged dividend of USD0.36 per share on the company's common stock, it declared on Tuesday.
Holders of the common stock of record at the close of business as of 8 November 2019 will receive the dividend payment on 2 December 2019.
According to the company, the fourth-quarter 2019 cash dividend will be its 324th consecutive quarterly dividend.
Pfizer said it works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time through collaborations with health care providers, governments and local communities.
Essa Pharma sets ex-dividend date and due bill trading for USD80m capital return
BioDlink's bevacizumab injection secures Colombia and Pakistan marketing authorisation
GSK to receive USD370m and future royalties in CureVac/BioNTech settlement
Ridgetech reports net income of USD10.20m in fiscal year 2025
Genomma Lab Internacional announces Q2 2025 results
Sanofi finalizes acquisition of Blueprint Medicines to expand rare disease and immunology portfolio
CVS Health declares quarterly dividend USD0.665 per share
Lilly declares dividend of USD1.50 for Q3
Bavarian Nordic sells US Priority Review Voucher for USD160m
Bavarian Nordic sells US Priority Review Voucher for USD160m
FDA grants priority review to Innoviva's zoliflodacin for treatment of gonorrhea